Questions? Please contact Kathleen Brieske via email.

Adrian Rich has more than 15 years of experience counseling high-growth, emerging companies and their investors. With an education in biomedical engineering and economics and a lifelong passion for computers and programming, Adrian brings a deep technological understanding and a unique approach to counseling clients from inception to exit, as they undertake financial and strategic investments, licensing, strategic partnerships, acquisitions and public offerings, as well as routine corporate matters. He tackles complex negotiations and issues, including deal structuring, reorganizations and down-rounds, using strong quantitative skills, coupled with creative problem solving.

Allison Glasunow, Ph.D. is experienced in patent preparation and prosecution in U.S. and foreign jurisdictions, post-grant review procedures at the U.S. Patent and Trademark Office, freedom to operate analysis and patent landscape analysis. Allison counsels clients on technical and legal matters concerning patentability and strategy to develop their patent portfolios. Her background includes patent matters involving clinical trials and product approvals at the Food and Drug Administration (FDA). In addition, Allison assists with due diligence and patent litigation matters.

Susan Betcher strengthens the business value of patent portfolios of publicly traded and privately held companies by creating intellectual property rights and then leveraging those rights via licensing agreements, competitive advantages in the marketplace, cross-jurisdictional partnerships and other arrangements. She helps clients define their IP strategies and how they can better commercialize their proprietary innovations.